Advanced Search

Diabetes & Endocrinology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

HEADS OF FACULTY

  • Photo of Paul Davis

    Paul Davis

    Ordway Research Institute Inc, Albany, NY, USA

  • Photo of Ele Ferrannini

    Ele Ferrannini

    Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

23
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Choi M, Scholl UI, Yue P, Björklund P, ..., Åkerström G, Wang W, Carling T, Lifton RP. Science. 2011 Feb 11; 331(6018):768-72

7 Evaluations, most recent by

Lee Weinstein, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, USA. F1000 Diabetes & Endocrinology

Past 7 Days

22

New Evaluations

4,696 total

12

New Articles Evaluated

3,102 total

Past 30 Days

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.